Earnings Feed
Start Free
REGENERX BIOPHARMACEUTICALS INC·4

Jun 12, 6:17 PM ET

MCNAY JOSEPH C 4

4 · REGENERX BIOPHARMACEUTICALS INC · Filed Jun 12, 2020

Insider Transaction Report

Form 4
Period: 2020-06-10
REGENERX BIOPHARMACEUTICALS INCRGRX
MCNAY JOSEPH C
Director
Transactions
  • Award

    Stock Option (right to buy)

    2020-06-10+250,000→ 250,000 total
    Exercise: $0.30Exp: 2030-06-10→ Common Stock (250,000 underlying)
Holdings

  • Stock Option (right to buy)

    Exercise: $0.19Exp: 2022-02-11→ Common Stock (100,000 underlying)
    100,000

  • Stock Option (right to buy)

    Exercise: $0.28Exp: 2027-09-01→ Common Stock (125,000 underlying)
    125,000

  • Stock Option (right to buy)

    Exercise: $0.21Exp: 2021-03-25→ Common Stock (120,000 underlying)
    120,000

  • Common Stock

    6,524,122

  • Stock Option (right to buy)

    Exercise: $0.21Exp: 2028-07-17→ Common Stock (200,000 underlying)
    200,000

  • Convertible Promissory Note (right to buy)

    Exercise: $0.12From: 2019-02-27Exp: 2024-02-27→ Common Stock (104,167 underlying)

  • Common Stock Warrant (right to buy)

    Exercise: $0.18From: 2019-08-27Exp: 2024-02-27→ Common Stock (78,125 underlying)
    78,125

  • Stock Option (right to buy)

    Exercise: $0.21Exp: 2029-05-15→ Common Stock (250,000 underlying)
    250,000
Footnotes (5)
  • [F1]100% vested.
  • [F2]31,250 shares vest on each of 9/1/17, 9/1/18, 9/1/19 and 9/1/20.
  • [F3]50,000 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.
  • [F4]62,500 shares vest on each of 5/15/19, 5/15/20, 5/15/21 and 5/15/22.
  • [F5]62,500 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT